“Clinical Evaluation of Ayurvedic Formulation Jeehv for its Ovulation Promoting Action in Females Suffering From Anovulation” by Dr. Aarati Patil, Dr. Divya C.S, and Dr. Gauri More published in the European Journal of Pharmaceutical and Medical Research
Gynoveda’s Ayurvedic supplement were found to be effective in assisting timely ovulation and thus can be useful in the management of infertility associated with gynecological disorders like PCOS, Irregular periods etc
The product was also found to be safe without causing any adverse effects
Gynoveda’s Ayurvedic supplement presented a success rate of 85.23% with 127 out of the 149 participants achieving ovulation in the span of 90 days at the latest
The clinical study is symbolic of Gynoveda’s vision of empowering women in India with an evidence-based medicinal system that delivers on-ground and tangible impact in women's healthcare by harnessing the power of Ayurveda
New Delhi: Gynoveda.com, an Ayurveda-backed women healthcare brand has taken a significant stride for women dealing with infertility issues. Its Ayurvedic supplement, recognized by European Journal of Pharmaceutical and Medical Research, was found to be effective in assisting timely ovulation and thus can be useful in the management of infertility associated with gynecological disorders like PCOS, Irregular periods etc. Conducted at Dhanwantari Ayurveda Centre, Pallakad, Kerala, India and amongst 149 participants (age group - 25-35 years) across India, the study reported 85.23% women achieving ovulation on time after consuming the Gynoveda’s Ayurvedic supplement (within 3 months). Moreover, no adverse drug reaction was observed offering women an opportunity to experience a safe motherhood.
Dr. Aarati Patil (MD, Ayurveda Gynaecology), Chief Doctor, Co-founder, and R&D Head, Gynoveda speaking about the breakthrough Ayurvedic formulation says, “With 15 years of experience in providing treatment to women grappling with severe gynecological disorders such as PCOS, fibroid, infertility, and endometriosis, I and my team are elated to have introduced a groundbreaking Ayurvedic supplement that possesses the potential to alleviate these disorders and conceive naturally.”
Gynoveda's Ayurvedic supplement has proven to be instrumental in assisting thousands of women in overcoming complications and achieving natural conception. This research paper is a testimony to Gynoveda’s mission to enable women to embrace the gift of motherhood.
Across the nation, women have enthusiastically shared their success stories, highlighting the efficacy of Gynoveda in their journey towards motherhood.
Chetna Jain from Mumbai says, “Gynoveda’s 3x program which includes Diet, Medicine and Doctor support is an all rounded plan that helped me in my journey of a successful pregnancy. Before turning to Ayurveda, I opted for IVF and it did not give me the result I was hoping for. As a last resort, I incorporated Gynoveda’s Ayurvedic supplement in my daily routine and it helped me conceive naturally and give birth to a healthy baby”
Furthermore, the study also reported that 123 women(82.55%) had complaints of irregular menstrual cycle which was normalized in 98 women. No adverse drug reactions were observed and the study products were well tolerated.
Despite being informed that conceiving would be unattainable, women who had spent significant time and resources on modern medicine were able to fulfill their dream of motherhood through the Gynoveda’s breakthrough Ayurvedic supplement. Gynoveda proudly celebrates mothers and mothers-to-be with their continuous effort.
About Gynoveda:
Gynoveda is the World’s first Ayurveda FemTech brand. It combines Ayurveda, Technology, Content & Community for women's healthcare, especially menstruation. Husband-wife duo Rachana & Vishal Gupta as founders of Gynoveda are on a mission to make Ayurveda as world’s first choice for women’s health from puberty to menopause. Gynoveda’s ayurvedic proprietary medicines with FDA approval have helped over 4 lakh women treat the root cause of disorders related to PCOS, irregular periods, infertility, pregnancy, skin, hair & general wellness. The company has delivered over 2 lakh orders across 20,000 pincodes in 58 major cities.
The company raised $10 million in March 2023 in Series A funding led by India Alternatives Fund. Since then its e-commerce platform Gynoveda.com is growing rapidly at 25% month-on-month and it's on track to cross ₹100 crores ARR in the current financial year. Gynoveda founders along with a team of doctors & scientists invented the world’s first Period Test, a gynecology bot that uses artificial intelligence (AI) to self-diagnose her reproductive health by answering a few questions on her mobile in just 2 minutes and getting results instantly.
Post a Comment